Focused on Every Breath
Diagnose Asthma with Confidence
Methapharm Respiratory’s ambition is to ensure people with asthma symptoms have the right diagnosis.
Methapharm Respiratory is part of Methapharm Specialty Pharmaceuticals.
Asthma is one of the most prevalent chronic respiratory conditions globally. Ensuring that patients have the right diagnosis is the first step in improving the lives of millions of people who struggle with the disease. We provide clinicians with the diagnostic tools to accurately assess people experiencing symptoms like cough, wheeze and shortness of breath. Our globally trusted diagnostic products are recommended in the ERS/ATS guidelines as well as other international practice guidelines.
Bronchial challenge tests with Provocholine (methacholine) and Aridol (mannitol), along with measuring the level of fractional exhaled nitric oxide (FeNO) in human breath using Vivatmo pro, are objective and evidence-based measures of airway hyperresponsiveness and inflammation. Both are key features of asthma. The right diagnosis is key.
As a committed partner, we also offer training and education (CRCE) at no cost to support clinicians as they help patients along their diagnostic journey.
NOW AVAILABLE!
NOW AVAILABLE!
Consider the consequences of an incorrect diagnosis of asthma:
Ineffective treatments
Inappropriate medications
Poor quality of life
Impact on work and school performance
Consider the consequences of an incorrect diagnosis of asthma:
Ineffective treatments
Inappropriate medications
Poor quality of life
Impact on work and school performance
Blog
Understanding Methacholine Chloride
For most Respiratory Therapists, and other health care workers in pulmonary diagnostics, methacholine chloride is a common, well-known bronchoprovocation agent. Provocholine® is the only FDA cleared methacholine chloride available for the methacholine challenge test...
Broken Heart Syndrome
What is “broken heart syndrome?” The medical term for broken heart syndrome is Takotsubo Cardiomyopathy. It was first described in 1990 by a Japanese physician, Dr. Hikaru Sato. He described a series of patients who presented as if they were having a heart attack...
Putting a Face to Supplemental Oxygen and the SOAR Act
My sister and I have Primary Ciliary Dyskinesia (PCD) and Bronchiectasis. In June of 2013 we were prescribed supplemental oxygen. My sister needed it 24/7 and I needed it for exertion. At that time, my sister had a 3 and 1-year-old at home. She was given oxygen tanks...